Chancery OKs Anixa Reform Deal To End Repriced-Stock Suit
A Delaware vice chancellor approved a deal on Tuesday that ends an Anixa Biosciences Inc. investor's derivative suit, which will institute governance changes to address claims company directors downpriced stock options...To view the full article, register now.
Already a subscriber? Click here to view full article